GLENMARK THERAPEUTICS INC., USA Trademark

Trademark Overview


On Monday, April 4, 2022, a trademark application was filed for GLENMARK THERAPEUTICS INC., USA with the United States Patent and Trademark Office. The USPTO has given the GLENMARK THERAPEUTICS INC., USA trademark a serial number of 97345574. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 24, 2023. This trademark is owned by Glenmark Therapeutics Inc., USA. The GLENMARK THERAPEUTICS INC., USA trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceutical preparations and chemical preparations for pharmaceutical or medical purposes
glenmark therapeutics inc., usa

General Information


Serial Number97345574
Word MarkGLENMARK THERAPEUTICS INC., USA
Filing DateMonday, April 4, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, July 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Goods and ServicesHouse mark for a full line of pharmaceutical preparations and chemical preparations for pharmaceutical or medical purposes
Disclaimer with Predetermined Text"THERAPEUTICS INC., USA"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateWednesday, July 6, 2022
First Use In Commerce DateMonday, August 1, 2022

Trademark Owner History


Party NameGlenmark Therapeutics Inc., USA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430

Party NameGlenmark Therapeutics Inc., USA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430

Trademark Events


Event DateEvent Description
Tuesday, July 25, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, July 24, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, July 24, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 27, 2023NON-FINAL ACTION E-MAILED
Monday, March 27, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, February 16, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 18, 2023USE AMENDMENT FILED
Thursday, February 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 18, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, May 11, 2022ASSIGNED TO EXAMINER
Friday, April 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 7, 2022NEW APPLICATION ENTERED